Laura A. Huppert

1.6k total citations · 2 hit papers
43 papers, 903 citations indexed

About

Laura A. Huppert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura A. Huppert has authored 43 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Laura A. Huppert's work include HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (9 papers) and Breast Cancer Treatment Studies (9 papers). Laura A. Huppert is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (9 papers) and Breast Cancer Treatment Studies (9 papers). Laura A. Huppert collaborates with scholars based in United States, India and Türkiye. Laura A. Huppert's co-authors include Michael A. Matthay, Lorraine B. Ware, Hope S. Rugo, Özge Gümüşay, Adil Daud, Damé Idossa, Briana M. Burton, Tatyana A. Sysoeva, Martha A. Zepeda‐Rivera and Christine Chow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Laura A. Huppert

37 papers receiving 888 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathogenesis of Acute Respiratory Distress Syndrome

2019 317 citations Laura A. Huppert, Michael A. Matthay et al. Seminars in Respiratory and Critical Care Medicine profile →
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

2023 96 citations Laura A. Huppert, Özge Gümüşay et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura A. Huppert United States	13	312	252	235	171	113	43	903
Stephen C. Yang United States	16	151 0.5×	293 1.2×	216 0.9×	193 1.1×	114 1.0×	41	951
Seon Mee Park South Korea	21	516 1.7×	471 1.9×	284 1.2×	131 0.8×	143 1.3×	122	1.4k
Jennifer M. Kwan United States	16	79 0.3×	145 0.6×	397 1.7×	159 0.9×	42 0.4×	51	1.2k
Jeffrey T. Cooper United States	17	157 0.5×	115 0.5×	357 1.5×	285 1.7×	291 2.6×	32	1.5k
Jillian H. Hurst United States	18	110 0.4×	105 0.4×	380 1.6×	77 0.5×	77 0.7×	61	811
Troy J. Plumb United States	14	108 0.3×	102 0.4×	171 0.7×	180 1.1×	28 0.2×	36	802
Oliver J. McElvaney Ireland	18	537 1.7×	161 0.6×	288 1.2×	249 1.5×	258 2.3×	41	1.2k
Yuan Huang China	18	70 0.2×	179 0.7×	404 1.7×	38 0.2×	150 1.3×	60	831
Deepak Darshan Australia	18	101 0.3×	50 0.2×	225 1.0×	52 0.3×	60 0.5×	27	1.1k
Steven T. Chen United States	14	184 0.6×	412 1.6×	113 0.5×	123 0.7×	32 0.3×	75	900

Countries citing papers authored by Laura A. Huppert

Since Specialization

Citations

This map shows the geographic impact of Laura A. Huppert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Huppert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Huppert more than expected).

Fields of papers citing papers by Laura A. Huppert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Huppert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Huppert. The network helps show where Laura A. Huppert may publish in the future.

Co-authorship network of co-authors of Laura A. Huppert

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Huppert. A scholar is included among the top collaborators of Laura A. Huppert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Huppert. Laura A. Huppert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahuron, Kelly M., Laura A. Huppert, Margaret M. Lowe, et al.. (2025). Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma. Cancer Research. 85(8). 1424–1440. 2 indexed citations

Dempsey, Naomi, Christine L. Moe, Laura A. Huppert, et al.. (2025). Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study.. Journal of Clinical Oncology. 43(16_suppl). 1015–1015. 4 indexed citations

Ríos-Hoyo, Alejandro, Erin F. Cobain, Laura A. Huppert, et al.. (2024). Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. 42(22). 2632–2636. 10 indexed citations

Ríos-Hoyo, Alejandro, Jiawei Dai, Christina Yau, et al.. (2024). Hormone Receptor–Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast Cancers. Clinical Cancer Research. 31(2). 403–413. 2 indexed citations

Huppert, Laura A., Harish N. Vasudevan, A. Jo Chien, et al.. (2024). Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study. Breast Cancer Research and Treatment. 206(3). 625–636.

Huppert, Laura A., Reshma Mahtani, Naomi Dempsey, et al.. (2024). Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC): Updated data and subgroup analyses by age, sites of disease, and use of intervening therapies.. Journal of Clinical Oncology. 42(16_suppl). 1083–1083. 7 indexed citations

Çil, Onur, A.S. Verkman, Matilda F. Chan, et al.. (2024). Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody–Drug Conjugates (ADCs). Current Ophthalmology Reports. 12(2). 13–22. 7 indexed citations

Baskin, Alison S., Laura A. Huppert, Tatiana Kelil, Lisa Singer, & Rita A. Mukhtar. (2024). The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes. 1(2). 100059–100059. 4 indexed citations

Kim, Mi‐Ok, Melanie Majure, John Park, et al.. (2024). Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer. Breast Cancer Research and Treatment. 204(3). 509–520. 2 indexed citations

10.

Huppert, Laura A., et al.. (2024). Changes in Gender and Racial/Ethnic Diversity in US Residency Program Applications From 2018 to 2022. Journal of Graduate Medical Education. 16(1). 37–40. 1 indexed citations

11.

Gümüşay, Özge, Laura A. Huppert, Mark Jesus M. Magbanua, et al.. (2023). A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. Breast Cancer Research and Treatment. 203(2). 197–204. 1 indexed citations

12.

Huppert, Laura A., Özge Gümüşay, Damé Idossa, & Hope S. Rugo. (2023). Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer. CA A Cancer Journal for Clinicians. 73(5). 480–515. 96 indexed citations breakdown →

13.

Huppert, Laura A., et al.. (2023). Metabolic Positron Emission Tomography in Breast Cancer. PET Clinics. 18(4). 473–485. 12 indexed citations

14.

Huppert, Laura A., Mi‐Ok Kim, Danielle Brandman, et al.. (2022). Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Research and Treatment. 197(1). 137–148. 7 indexed citations

15.

Thomas, Alexandra, Amy S. Clark, Christina Yau, et al.. (2022). Molecular subtype to predict pathologic complete response in HER2-positive breast cancer in the I-SPY2 trial.. Journal of Clinical Oncology. 40(16_suppl). 510–510. 1 indexed citations

16.

Isaza, Erin, et al.. (2022). Tumor Fever Due to Metastatic Esophageal Squamous Cell Carcinoma. The American Journal of Medicine. 135(8). e294–e295.

17.

Huppert, Laura A., et al.. (2021). Emerging immunotherapeutic strategies for the treatment of breast cancer. Breast Cancer Research and Treatment. 191(2). 243–255. 9 indexed citations

18.

Huppert, Laura A., Michael D. Green, Luke Kim, et al.. (2021). Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy. Cellular and Molecular Immunology. 19(1). 33–45. 84 indexed citations

19.

Huppert, Laura A., Lekshmi Santhosh, & Jennifer M. Babik. (2021). Trends in US Internal Medicine Residency and Fellowship Applications During the COVID-19 Pandemic vs Previous Years. JAMA Network Open. 4(4). e218199–e218199. 22 indexed citations

20.

Huppert, Laura A., Michael A. Matthay, & Lorraine B. Ware. (2019). Pathogenesis of Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine. 40(1). 31–39. 317 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact